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Abstract
NaV1.5 is a cardiac voltage-gated Na
+ channel asubunit and is encoded by the SCN5a gene. The activity of this channel
determines cardiac depolarization and electrical conduction. Channel defects, including mutations and decrease of channel
protein levels, have been linked to the development of cardiac arrhythmias. The molecular mechanisms underlying the
regulation of NaV1.5 expression are largely unknown. Forkhead box O (Foxo) proteins are transcriptional factors that bind
the consensus DNA sequences in their target gene promoters and regulate the expression of these genes. Comparative
analysis revealed conserved DNA sequences, 59-CAAAACA-39 (insulin responsive element, IRE), in rat, mouse and human
SCN5a promoters with the latter two containing two overlapping Foxo protein binding IREs, 59-CAAAACAAAACA-39. This
finding led us to hypothesize that Foxo1 regulates NaV1.5 expression by directly binding the SCN5a promoter and affecting
its transcriptional activity. In the present study, we determined whether Foxo1 regulates NaV1.5 expression at the
transcriptional level and also defined the role of Foxo1 in hydrogen peroxide (H2O2)-mediated NaV1.5 suppression in HL-1
cardiomyocytes using chromatin immunoprecipitation (ChIP), constitutively nuclear Foxo1 expression, and RNAi Foxo1
knockdown as well as whole cell voltage-clamp recordings. ChIP with anti-Foxo1 antibody and follow-up semi-quantitative
PCR with primers flanking Foxo1 binding sites in the proximal SCN5a promoter region clearly demonstrated enrichment of
DNA, confirming Foxo1 recruitment to this consensus sequence. Foxo1 mutant (T24A/S319A-GFP, Foxo1-AA-GFP) was
retained in nuclei, leading to a decrease of NaV1.5 expression and Na
+ current, while silencing of Foxo1 expression by RNAi
resulted in the augmentation of NaV1.5 expression. H2O2 significantly reduced NaV1.5 expression by promoting Foxo1
nuclear localization and this reduction was prevented by RNAi silencing Foxo1 expression. These studies indicate that Foxo1
negatively regulates NaV1.5 expression in cardiomyocytes and reactive oxygen species suppress NaV1.5 expression through
Foxo1.
Citation: Mao W, You T, Ye B, Li X, Dong HH, et al. (2012) Reactive Oxygen Species Suppress Cardiac NaV1.5 Expression through Foxo1. PLoS ONE 7(2): e32738.
doi:10.1371/journal.pone.0032738
Editor: Rossella Rota, Ospedale Pediatrico Bambino Gesu’, Italy
Received November 1, 2011; Accepted January 30, 2012; Published February 29, 2012
Copyright:  2012 Mao et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: HX is supported by grants from National Institute of Health (NIH) (K08HL088127) and American Heart Association (AHA) (12GRNT9690003); JAH is
supported by grants from NIH (HL-075173, HL-080144 and HL-090842), AHA (0640084N), AHA-Jon Holden DeHaan Foundation (0970518N) and American
Diabetes Association (7-08-MN-21); HHD is supported by grants from NIH (DK066301 and DK087764); FL is supported by grant from AHA and the Lawrence J. and
Florence A. DeGeorge Charitable Trust (10GRNT4460014). The funders had no role in study design, data collect and analysis, decision to publish, or preparation of
the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: Haodong_Xu@URMC.Rochestser.edu
. These authors contributed equally to this work.
¤ Current address: Department of Anesthesiology, Union Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei,
People’s Republic of China
Introduction
Alterations of ion channel activity play an important role in the
development of cardiac arrhythmias. NaV1.5 encoded by the
SCN5a gene is a subunit of the voltage-gated cardiac Na
+ channel,
and this channel activity determines cardiac excitability and
conduction. Reactive oxygen species (ROS) are generated during
myocardial infarction [1–4] and contribute to the development of
life-threatening ventricular arrhythmias [5,6]. It has been shown
that alteration of cardiac Na
+ channel activity immediately
following ROS challenge requires activation of Ca
2+-dependent
calmodulin II kinase (CaMKII) [7]. CaMKII regulates Na
+
channel gating by phosphorylating NaV1.5 to increase late Na
+
current, leading to the prolongation of the action potential
duration and development of early afterdepolarization [8]. H2O2-
chronically mediated downregulation of Na
+ channel activity
requires activation of NF-KappaB to decrease NaV1.5 expression
by inhibiting SCN5a promoter activity [9]. Mutation of the NF-
KappaB binding site in the SCN5a promoter eliminates 42.3%
decrease of this promoter activity by H2O2 in H9C2 myoblasts [9].
These findings indirectly support the notion that other signaling
pathways are also significantly involved in the regulation of
NaV1.5 expression.
Foxo transcription factors form a subclass of the large family of
Forkhead proteins characterized by the presence of a ‘‘winged-
helix’’ DNA-binding domain called Forkhead box O, which gave
the name Foxo proteins to the family [10]. Post-translational
modifications such as phosphorylation, acetylation and methyla-
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[11–13]. Foxo proteins harbor conserved threonine and serines
that can be phosphorylated by different kinases, leading to their
nuclear retention or exclusion [11]. Akt/protein kinase B (PKB)
[14,15], serum and glucocorticoid-induced kinase 1 (SGK1) [16],
cyclin-dependent kinase 2 (CDK2) [17] and IkB kinase (IKK) [18]
phosphorylate Foxo proteins, resulting in their nuclear exclusion
while c-Jun-N-terminal kinase (JNK) [19] and mammalian sterile
20-like kinase 1 (MST1) [20] phosphorylate Foxo proteins, causing
their nuclear retention. Foxo proteins also contain acetylated
lysines that can be deacetylated by a NAD-dependent histone
deacetylase, silent mating type information regulation 2 homolog
(Sirt1), leading to their nuclear retention [12]. Protein arginine
methyltransferase 1 (PRMT1) methylates Foxo1 primarily at
Arg248 and Arg250 within the consensus Akt phosphorylation
motif. These methylations directly abrogate Akt-induced phos-
phorylation of Foxo1 at Ser253, which in turn results in increased
Foxo1 nuclear localization [13]. Accumulating evidence suggests
that Foxo1, 3 and 4 are expressed in the heart and they are critical
in maintaining cardiac function and mediating cardiac stresses. In
the heart, the Foxo family is believed to be involved in diverse
activities, including response to oxidative stress [21–23], regulation
of metabolism [24], modulation of KATP channels [25],
promotion of autophagy [26], cell cycle control [27,28], and
commitment to apoptosis [29]. In the nucleus, Foxo proteins
target a conserved DNA binding sequence, 59-GTAAA(C/T)A-39
[30] or insulin response element (IRE), 59-CAAAA(C/T)A-39 [30–
32] in the promoters of their target genes to affect these gene
expression. The end result of Foxo transcriptional activity is
generally associated with counteracting oxidative stress and
promoting cell cycle arrest and apoptosis [11]. Silico promoter
analysis on a list of 354 of the most differentially expressed genes in
the thymocyte lineage predicted that the promoter of SCN5a has
Foxo binding elements [33].
In this study, we tested the hypothesis that H2O2 suppressing
NaV1.5 requires the Foxo1 signaling pathway. Our results showed
that Foxo1 negatively regulated NaV1.5 expression by directly
binding the SCN5a promoter, and H2O2-mediated inhibition of
NaV1.5 expression required Foxo1.
Materials and Methods
Ethics
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol was approved by the University Committee on Animal
Resources (UCAR) of University of Rochester Medical Center
(UCAR # 2007-060).
Cell Culture
HeLa cells (obtained from American Type Culture Collection)
were maintained in 10 cm plates containing Dulbecco’s modified
Eagle’s medium (high glucose) and 10% fetal bovine serum with
100 U/ml penicillin and 100 mg/ml streptomycin. A cardiomyo-
cyte cell line, designated HL-1, from the AT-1 mouse atrial
cardiomyocyte tumor lineage, was kindly provided by Dr. William
C. Claycomb at Louisiana State University Health Sciences
Center, New Orleans, USA. These cells were cultured as described
previously [34]. The cells were cultured in Claycomb medium
(JRH Biosciences, KS) supplemented with 10% fetal bovine serum
(JRH Biosciences, KS), 2 mM L-glutamine, 100 mM norepineph-
rine, 100 U/ml penicillin and 100 mg/ml streptomycin in 10 cm
plates pre-coated with fibronectin (BD Biosciences, PA). The
medium was changed every 24–48 h. Mouse ventricular myocytes
isolated from 10 week old FVB mice as previously described [35]
were directly subjected to a chromatin immunoprecipitation
(ChIP) assay.
Bioinformatics
The SCN5a genomic promoter sequences from mouse, rat, and
human were downloaded from the University of California Santa
Cruz genome browser [36] and comparative genomic analysis was
done with the visualization tools for alignments (VISTA) algorithm
(available from the VISTA web site). The Foxo protein biding
sequences were compared.
Transfection and Luciferase Assays
Lipofectamine
TM and plus
TM reagents (Invitrogen) were used
to transfect SNC5a reporters (SCN5a promoter-Luc plasmid [37]
was generously provided by Dr. Hideko Kasahara in University of
Florida College of Medicine, Florida, USA) and Foxo1 in the HeLa
cells. Cells were seeded in 24-well plates and grown to 90%
confluence. Transfections were performed according to the
manufacturer’s instructions. A Renilla reporter gene (Promega)
was included as an internal control. Cell lysates were prepared for
the luciferase assay 24 hours after transfection as described by the
manufacturer (Promega). Data were analyzed and expressed as the
normalized-fold changes over controls.
RT-PCR
Total RNA was extracted from HL-1 and HeLa cells by
RNeasy Mini kit (QIAGEN) and reversely transcribed to cDNA
with a high capacity cDNA reverse transcription kit (AB Applied
Biosystems). Semi-quantitative PCR was conducted to measure
mRNA expression levels across different experimental conditions
as indicated under ‘‘Results’’. The primers used to amplify
mouse(m) NaV1.5, mß-actin, human(h) GAPDH, mGAPDH,
hFoxo1, and mTR4 were summarized in table 1.
Western Blotting
HL-1 cells were rinsed with phosphate-buffered saline (PBS)
twice, and protein was extracted in cold cell lysis buffer (Cell
Signaling). Protein concentration was determined by a detergent-
compatible protein assay (Bio-Rad). Equal amounts of protein
were resolved by SDS-PAGE, transferred onto nitrocellulose
membranes, blocked with 5% non-fat milk for 1 hour, and then
incubated with the indicated primary antibody overnight at 4uC.
After 1 hour incubation with the appropriate secondary antibody,
specific signals were revealed by enhanced chemiluminescence
reagent (Pierce). The primary antibodies used were as follows:
rabbit anti-Foxo1 polyclonal (Cell Signaling, 1:1000), rabbit anti-
NaV1.5 polyclonal (Alomone Labs, 1:500), rabbit anti-GAPDH
polyclonal (Millipore, 1:4000), and mouse anti-tubulin monoclonal
(Sigma, 1:5000).
Fluorescen and Confocal Microscopy
HL-1 cells were dispersed on the glass in the center of the
32 mm dishes and grown to 80% confluence. HL-1 cells
expressing GFP and Foxo1-GFP were fixed with 4% paraformal-
dehyde. Nuclear profiles of were revealed with a brief incubation
in DAPI (Molecular Probes) prior to microscopic observation.
Fluorescence was visualized with an inverted Olympus IX81
fluorescence confocal microscope and photographed for direct
import into Image J. All images were processed in an identical
manner to faithfully capture the real time images of each sample.
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The adenoviral vectors used were as follows: Adv–CMV-
FoxO1-AA-GFP expressing constitutively nuclear FoxO1-AA-
GFP and Adv-CMV-GFP expressing GFP. Adv–FoxO1-RNAi
vector was constructed based on the Block-iT Adenoviral RNAi
Expression System (Invitrogen). This FoxO1-RNAi vector encodes
a 19-bp DNA (59-CGCCCCAGGTGGTGGAGAC-39) that is
complementary to the Foxo1 mRNA sequence (10–29 nt) under
the control of the mouse U6 promoter. Likewise, a control
adenovirus containing the scrambled RNAi (59-GGACTCGGGC-
CACCGGGTA-39) (Adv-scramble-RNAi) under the control of
mouse U6 promoter was constructed.
ChIP Assay
ChIP was used to study the interaction between Foxo1 and
SCN5a promoter DNA in HL-1 cells, as previously described [38].
Approximately 1610
7 HL-1 cells were subjected to the ChIP assay
using anti-Foxo1 antibody or rabbit control IgG as a control and
the ChIP assay kit (Upstate Biotechnology), as previous described
[38]. The immunoprecipitates were analyzed by immunoblot
analysis using goat anti-Foxo1 (FKHR-C20; Santa Cruz Biotech-
nology Inc.), and by PCR assay to detect coimmunoprecipitated
DNA using two pairs of SCN5a promoter–specific primers (forward
59-TGGTACATACCGTTTCAGGAC-39 and reverse 59 GCA-
CACACACTCACACATAC -39; forward 59- TGGTACATA-
CCGTTTCAGGAC-39 and reverse 59-ACGCATGCTCACG-
CACACA -39) that flank the consensus Foxo1 binding sites
(21484 to 21473 nt) in the mouse SCN5a promoter and a pair of
primers (forward 59- GCCTCATTCGTTGCAGTGTGCC-39
and reverse 59-GCCAGTGCCTTGTGTGGACTCT-39) that
flanked the DNA sequence (24453 to 24686) lacking Foxo1
biding site as a control.
Whole-cell Voltage Clamp Recording
Na
+ currents were recorded from HL-cells using whole-cell
patch-clamp techniques at room temperature (22–24uC). The bath
solution for recording membrane currents contained (in mM) 145
NaCl, 4.5 CsCl, 1.5 MgCl2, 1 CaCl2, 5 HEPES, 5 glucose, 0.1
CdCl2 (pH 7.35 with CsOH); the pipette solution contained (in
mM) 10 NaF, 110 CsF, 20 CsCl, 10 EGTA, and 10 HEPES
(pH 7.35 with CsOH). Electrode resistance ranged from 2.0 to
3.0 MV. Data acquisition was carried out using an Axopatch 200B
amplifier and pClampex 9.6 software (Axon Instruments Inc.,
Foster, CA). Currents were acquired at 20–50 kHz (Digidata 1200
A/D converter; Axon Instruments Inc.) and low-pass-filtered at
5 kHz, and stored on a computer. In all recordings, 80% of the
series resistance was compensated. Data analysis was accom-
plished by using pClampfit 9.6 software (Axon Instruments Inc.,
Foster City, CA).
Statistical Analysis
All values are expressed as Mean6SEM. Data from experi-
mental groups were compared by student’s t-test or ANOVA one
way analysis. A value of p,0.05 was considered statistically
significant.
Results
The Proximal Region of SCN5a Promoter Contains Foxo1
Responsive Elements
Silico promoter analysis on a list of 354 of the most differentially
expressed genes in the thymocyte lineage has revealed putative
direct targets that are transcriptionally regulated by Foxo proteins
in thymocytes, and that SCN5a transcription is upregulated by
Foxos deletion [33]. These findings suggest that transcription of
SCN5A may be directly regulated by Foxos in cardiomyocytes.
Analysis of the SCN5a promoter region showed a highly conserved
DNA sequence (59-CAAAACA-39) as IRE in humans and rodents
such as mouse and rat. The mouse and human SCN5a promoter
regions harbor two overlapping Foxo1 binding IREs, 59-
CAAAACAAAACA-39 (Fig. 1A).
Foxo1 directly binds SCN5a promoter
To confirm the association of Foxo1 with the SCN5a promoter
region including IREs, a ChIP assay was carried out in HL-1 cells
and mouse ventricular myocytes, and it unveiled a clear
enrichment of DNA amplified by PCR with two sets of primer
pairs flanking Foxo1 binding IREs (59-CAAAACAAAACA-39)i n
the proximal SCN5a promoter region following immunoprecipita-
tion with Foxo1 antibody, but not with IgG control (Fig. 1B).
Another pair of primers was designed to amplify a region away
from Foxo1 binding site, 59-CAAAACA-39. As showed in Figure
S1, there was no PCR product detected after chromatin
immunoprecipitation by Foxo1 antibody.
Foxo1 Negatively Regulates SCN5a Promoter Activity
This conserved sequence is located from 21484 to 21473 in
the mouse SCN5a promoter region. The proximal promoter region
(22308 to +119 bp) was examined in luciferase reporter assays in
HeLa cells with and without expression of Foxo1 (Fig. 2A).
Expression of Foxo1 significantly suppressed SCN5a promoter
activity (p,0.01), and the suppression was Foxo1 dose dependent
(Fig. 2B). Individual (CAAAAC to CCCAAC) or double mutations
(CAAAACAAAACA to CCCAACCCAACA) in Foxo1 binding
Table 1. Summary of primers for RT-PCR.
Forward Primer Reverse Primer
m1NaV1.5 59-ACAGGCCTCCAAAAAGCTGCCAGA-39 59-GGGTCGTGTTGTGCCATGAACACA-39
m2NaV1.5 59-CAGGTCGGAAACTTGGTCTTCAC-39 59-GAAGATGATGAAAGTCTCGAACCA-39
mb-actin 59-AGATGTGGATCAGCAG-39 59-GCGCAAGTTAGGTTTTGTCA-39
hGAPDH 59-ACGGATTTGGTCGTATTGGG-39 59-CGCTCCTGGAAGATGGTGAT-39
mGAPDH 59-TGAACGGATTTGGCCGTATTGGGC-39 59-TCTTCTGGGTGGCAGTGATGGCAT-39
hFoxo1 59-AACCTGTCCTACGCCGACCTCA-39 59-GCTCGGCTTCGGCTCTTAGCAA-39
mTR4 59-GTAGCCTCACCTCAGCGCATTCA-39 59-GCGGTTACGGTGGTGCTTGTTG-39
Note: m, mouse; h, human.
doi:10.1371/journal.pone.0032738.t001
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compared with wild type SCN5a, and double mutations of Foxo1
were significantly more effective (p,0.05) than mutation 1 on
SCN5a promoter activity (Fig. 2C).
Foxo1 Negatively Regulates NaV1.5 Expression in HL-cells
HL-1 cells harbor robust, rapidly activated and inactivated Na
+
currents [39], indicating that NaV1.5 is expressed in HL-1 cells. In
order to test the hypothesis that Foxo1 regulates NaV1.5
expression, HL-1 cells were used in the study. The HL-1 cells
were infected for 48 hours by 10 or 50 multiplicity of infection
(MOI) adenoviruses (Adv)-CMV-Foxo1-AA-GFP [40] and 50
MOI Adv-CMV-GFP. Western blot analysis of the protein
extracts from these infected HL-1 cells was performed, and
showed that NaV1.5 protein was more significantly decreased
(p,0.05 or p,0.01) in cells expressing constitutively nuclear Foxo-
1-AA-GFP (AA: T24A/S319A) compared to cells expressing GFP
(Fig. 3A and C). Interestingly, endogenous Foxo1 was significantly
increased by overexpression of Foxo1-AA-GFP (Fig. 3A). This
finding is consistent with a previous report that Foxo1 can be
positively regulated by Foxo1 binding its own promoter [41].
Accordingly, NaV1.5 mRNA level determined by semi-quantita-
tive RT-PCR analysis was also significantly decreased (p,0.01) in
HL-1 cells expressing Foxo1-AA-GFP compared to HL-cells
expressing GFP (Fig. 3B and D). This pair of primers (m1NaV1.5)
for RT-PCR application was designed to detect two splicing
variants, NaV1.5a and NaV1.5b [42]. In order to determine if
Foxo1 affects the expression of these two splicing variants, the
second pair of primers (m2NaV1.5) was designed to allow us to
detect NaV1.5, NaV1.5a and NaV1.5b. Unfortunately, there was
only one band of PCR product at 1300 bp detected, which
consistently showed the inhibition of NaV1.5 expression by Foxo1-
AA-GFP in HL-1 cells (Figure S2). This has prevented us from
addressing if Foxo1 also affects the expression of other splicing
variant(s).
Figure 1. Foxo1 directly binds the insulin response elements in
SCN5a promoter region. A. Analysis of proximal region of the SCN5a
promoter showed two overlapping conservative Foxo binding insulin
response elements, 59-CAAAACA-39, in rat, mouse and human. B. ChIP
assay showed that Foxo1 bound SCN5a promoter region in both HL-1
cells (upper panel) and adult mouse ventricular myocytes (lower panel)
using two sets of paired primers, respectively. Lane 1 and 2 were input
and IgG, respectively.
doi:10.1371/journal.pone.0032738.g001
Figure 2. Foxo1 decreases SCN5a promoter activity. A. Luciferase
constructs contain proximal region of SCN5a promoter which has Foxo1
binding insulin response elements and mutations. B. Foxo1 significantly
suppressed SCN5a promoter activity with dose dependence (**p,0.01,
n=3). C. Individual or double mutations of Foxo1 binding sites in SCN5a
promoter region prevented Foxo1 inhibition (**p,0.01) compared with
wild type SCN5a; Double mutation of Foxo1 binding sites had
significantly more effective (
#p,0.05) than mutation 1 (n=6 in all
individual groups).
doi:10.1371/journal.pone.0032738.g002
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HL-1 cells (Fig. 3A and B). To test the hypothesis that a decrease
of endogenous Foxo1 expression upregulates NaV1.5 expression,
Adv–FoxO1-RNAi was used to infect HL-1 cells to express RNAi
and silence Foxo1 expression (Fig. 4A). The downregulation of
Foxo1 induced a significant increase in both NaV1.5 protein
(p,0.05, at 100 MOI) (4A and C) and mRNA levels (p,0.01, at
100 MOI) in HL-1 cells (4B and D) when compared with those
obtained from the cells infected with Adv-scramble-RNAi. This
FoxO1-RNAi construct encodes a 19-bp oligonucleotide (59-
CGCCCCAGGTGGTGGAGAC-39) that is complementary to
the mouse Foxo1 mRNA sequence (10–29 nt). This sequence has
two nucleotides different from that of human Foxo1 mRNA and
one nucleotide at the most 59 different from that of TR4 mRNA -
encoded by Nrc2c gene. In order to determine the specificity of this
RNAi, human HeLa cells expressing endogenous Foxo1 [43] and
HL-1 cells were infected with Adv-Foxo-RNAi and Adv-scramble-
RNAi, respectively. RT-PCR analysis showed that Foxo1 mRNA
in HeLa cells and TR4 mRNA in HL-1 cells were not altered by
expression of Adv-Foxo1-RNAi (Figure S3 and S4), indicating that
RNAi specifically targeted mouse Foxo1 mRNA.
Foxo1 Nuclear Localization Reduces Na
+ Currents in HL-1
cells
To test the hypothesis that activation of Foxo1 reducing NaV1.5
expression decreases functional Na
+ currents, whole-cell voltage-
clamp Na
+ current recordings were performed on HL-1 cells
infected with 50 MOI Adv-CMV-GFP and 50 MOI Adv-CMV-
Foxo1-AA-GFP for 48 hours, respectively. Foxo1-AA-GFP was
localized in the nuclei (Fig. 5B), while GFP was seen in both
cytoplasm and nuclei (Fig. 5A). Recording traces of rapidly
activating and inactivating Na
+ currents from GFP and Foxo1-
AA-GFP-expressing cells, respectively, 36 hours after adenovirus
infection, are illustrated in Figure 5C and D. Na
+ currents were
significantly inhibited by expression of Foxo1-AA-GFP, and peak
Na
+ current density was significantly lower (p,0.01) in cells
expressing Foxo1-AA-GFP (19.665.6 pA/pF, at 225 mV) than in
cells expressing GFP (67.969.6 pA/pF, at 225 mV).
H2O2 Promoting Foxo1 Nuclear Localization Reduces
NaV1.5 Expression
H2O2 Promotes Foxo1 nuclear localization: HL-1 cells were infected
with 50 MOI Adv-CMV-Foxo1-GFP and 50 MOI Adv-CMV-
GFP. These infected cells were cultured for 36 hours. Fifty mM
H2O2 was then added to the culture medium. Fluorescent and
confocal images showed that 2 hours of treatment with H2O2
promoted Foxo1-GFP to localize in nuclei, but not GFP (Fig. 6).
H2O2 inhibiting NaV1.5 expression is through the Foxo1 signaling
pathway: Increase of Foxo1 nuclear localization by H2O2 is
expected to reduce NaV1.5 expression. In order to confirm this
assumption, RNA and protein were extracted from HL-1 cells
treated with 25 mMH 2O2 for 48 hours. Analyses of RT-PCR
products and Western blot results showed that both NaV1.5
protein and mRNA levels were significantly decreased (p,0.05)
Figure 3. Constitutively nuclear Foxo1 reduced NaV1.5 expression. Western blots showed that overexpression of Foxo1-AA-GFP for 36 hours
reduced NaV1.5 protein level while it increased endogenous Foxo1 expression (A); quantitiation of NaV1.5 protein level relative to GAPDH revealed
that expression of Foxo1-AA-GFP (n=5) significantly decreased (*p,0.05, at 10 MOI; **p,0.01 at 50 MOI) NaV1.5 expression compared with 50 MOI
GFP (n=5) (C). RT-PCR showed that overexpression of 50 MOI Foxo1-AA-GFP for 36 hours decreased NaV1.5 mRNA level compared with that in cells
expressing 50 MOI GFP (B) and the values of NaV1.5 mRNA relative to ß-actin between GFP (n=4) and Foxo1-AA-GFP (n=4) groups were significantly
different **(p,0.01) (D).
doi:10.1371/journal.pone.0032738.g003
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100 MOI Adv-Foxo1 RNAi (n=4) increased NaV1.5 protein in HL-1 cells in comparison with 100 MOI Adv-scramble RNAi (n=4) (A) and this inhibition
reached the significant difference (*p,0.05) at 100 MOI Adv-Foxo1-RNAi (C). RT-PCR showed that NaV1.5 mRNA was increased by 50 MOI Foxo1-RNAi
(n=4) in comparison with that in cells expression scramble RNAi (n=4) (B). The values of NaV1.5 mRNA relative ß-actin between Foxo1-RANi and
scramble RNAi groups were significant different (**p,0.05) (D).
doi:10.1371/journal.pone.0032738.g004
Figure 5. Foxo1 inhibits Na
+ channel activity. Foxo1-AA-GFP was localized in HL-1 cardiomyocyte nuclei (B) while GFP was seen in both nuclei
and cytoplasm (A). Whole cell Na
+ currents were recorded during 80 ms depolarizing voltage steps to potentials between 260 and +60 mV from a
holding potential of 2100 mV in HL-1 cells expressing GFP or Foxo1-AA-GFP for 36 hours. The typical whole cell recording traces showed that robust
Na
+ currents were present in HL-1 cells expressing GFP (C) while remarkable reduction of Na
+ currents in these cells expressing Foxo1-AA-GFP (D).
doi:10.1371/journal.pone.0032738.g005
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determine if H2O2 reducing NaV1.5 expression was through the
Foxo1 signaling, 100 MOI Adv-scramble RNAi and 100 MOI
Adv-Foxo1-RNAi were used to infect HL-1 cells and 25 mMH 2O2
was added in the culture medium after the cells expressed
scramble RNAi and Foxo1-RNAi for 24 hours. Both NaV1.5
mRNA and protein levels were significantly increased (p,0.05
and p,0.01, respectively) in the cells expressing Foxo1 RNAi with
a 48-hour H2O2 treatment when compared with the cells
expressing scramble RNAi with 48 hour H2O2 treatment
(Fig. 8A, C and B, D).
Discussion
Foxo1 negatively regulates NaV1.5 expression
Foxo1 is known to function primarily as a transcription factor.
The results presented here demonstrate that Foxo1 directly binds
the IRE in the SCN5a promoter region and inhibits its promoter
activity. This inhibition leads to downregulation of NaV1.5
expression and a decrease of cardiac Na
+ channel activity. In
the nucleus, Foxo proteins bind a conserved DNA binding
sequence, 59-GTAAA(C/T)A-39 [30] or IRE, 59-CAAAA(C/T)A-
39 [30–32] in the promoter regions of the targeted genes. Foxo
recruitment to the promoter regions usually positively regulates
expression of the target genes. For example, Foxo1 bound the
consensus sequence in the Kir 6.1 gene promoter and increased
the expression of KATP subunit Kir6.1 [25]. In the literature,
there is one report in which the authors identified Foxo1 as a
corepressor for androgen receptor (AR) [44]. Some corepressors
possess intrinsic histone deacetylases (HDAC) activity and some
repress gene expression through recruitment of HDAC proteins
[45]. It has been shown that HDAC3, but not HDAC1 and
HDAC2 associate with Foxo1, enhancing Foxo1-induced inhibi-
tion of AR function in LNCaP cells [46]. Whether Foxo1 recruits
HADC3 to inhibit the SCN5a promoter activity remains
undetermined.
H2O2 suppressing NaV1.5 expression requires Foxo1
ROS have been shown to acutely enhance late Na
+ currents,
leading to action potential prolongation and early afterdepolariza-
tions [47–49] via activating CamKII [8,7] and phosphorylating
NaV1.5. ROS have also been reported to acutely reduce fast
transient outward K
+ current, leading to the prolongation of
cardiac repolarization by phosphorylating Kv4.3 [50]. The
chronic effects of H2O2 on NaV1.5 expression were also well
studied [9]. NaV1.5 expression was suppressed by H2O2 activating
NF-KappaB and partially inhibiting SCN5a promoter activity [9].
These findings indicate that other mechanisms are also involved in
the regulation of NaV1.5 expression at the transcriptional level. As
reflected in our studies, H2O2 reduced NaV1.5 expression by
promoting Foxo1 nuclear localization, and Foxo1 signaling is
required for H2O2 to affect NaV1.5 expression. ROS modulate
Foxo1 subcellular localization through different pathways. H2O2
inhibits phosphorylation of Foxo1 at Ser-253 and The-24 by
reducing Akt kinase activity in response to insulin [12]. Under
oxidative stress, the activated JNK pathway decreases the activity
of Akt in HIT cells, leading to the decrease of phosphorylation of
Foxo1 and promoting its nuclear localization [51]. Oxidative stress
also augments PRMT1-induced Foxo1 methylation, thereby
leading to the inhibition of its phosphorylation by Akt and
promotion of its nuclear localization [13]. Sirt1 has been reported
to be activated by H2O2 and the subsequently activated Sirt1
deacetylates and entraps Foxo1 in the nucleus, which is also
independent of H2O2-induced dephosphorylation of Foxo1 [12].
It is likely that Sirt1, Akt, JNK and PRMT1 signaling pathways
are involved in the regulation of NaV1.5 expression under
oxidative stress. Foxo4 has been shown to interact with NF-
KappaB and subsequently inhibit its transcriptional activity [52].
Whether Foxo1 suppressing NaV1.5 expression in cardiac
myocytes is also partially through the NF-KappaB signaling
pathway remains to be verified.
Novelty and Potential Significance
ROS including H2O2 are significantly elevated in ischemic
heart disease (IHD), [1–4] in which arrhythmias are frequently
observed. A significant decrease in Na
+ channel activity is
considered to be one of mechanisms contributing to the
development of arrhythmias in IHD [5,6]. The mechanisms of
transcriptional regulation of NaV1.5 expression are largely
uncertain. In this study, we demonstrated that Foxo1 directly
targeted the SCN5a promoter and inhibited its transcriptional
activity. Furthermore, we confirmed that H2O2 promoted Foxo1
nuclear translocation. This Foxo1 relocation is required for H2O2-
mediated NaV1.5 downregulation. These findings indicate the
important role of Foxo1 in cardiac ion channel regulation and in
the development of arrhythmias.
Figure 6. H2O2 promotes Foxo1 nuclear localization. HL-1 cells
were treated with 50 MOI Adv-CMV-GFP or 50 MOI Adv-CMV-Foxo1-GFP
for 36 hours and then, 50 mMH 2O2 was added in the medium. GFP was
expressed in both cytoplasm and nuclei and its localization was not
altered by 2 hour H2O2 treatment (A) while Foxo1-GFP was expressed in
the cytoplasm and 2 hour H2O2 treatment promoted Foxo1-GFP
nuclear localization (B). All images were taken with Ix81 fluorescence
confocal microscopy.
doi:10.1371/journal.pone.0032738.g006
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treated with 25 mMH 2O2 for 48 h hours (n=3) compared with the control group (n=3) (A, C). RT-PCR analysis showed that NaV1.5 mRNA significantly
reduced (p*,0.05) in HL-1 cells treated with 25 mMH 2O2 for 48 hours (n=3) compared with the control group (n=4) (B, D).
doi:10.1371/journal.pone.0032738.g007
Figure 8. H2O2 -mediated downregulation of NaV1.5 requires Foxo1. Western blot analysis showed that NaV1.5 protein was significantly
increased(*p,0.05)inHL-1cellsculturedinthemediumwith25 mMH 2O2treatmentfor48 hoursafterthecellsexpressedFoxo1-RNAifor24 hours(n=4)
compared withscramble RNAi group (n=4)(A, C). RT-PCRanalysis showedthatNaV1.5 significantly increased (**p,0.01) in HL-1cells in the mediumwith
25 mMH 2O2 treatment for 48 hours after the cells expressed Foxo1-RNAi for 24 hours (n=4) compared with scramble RNAi group (n=4) (B, D).
doi:10.1371/journal.pone.0032738.g008
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Figure S1 Foxo1 does not bind the SCN5a promoter region
lacking the insulin responsive element. A pair of primers was
designed to amplify a region far away from Foxo1 binding site, 59-
CAAAACA-39. There was no PCR product detected after
chromatin immunoprecipitation (ChIP) by Foxo1 antibody (Lane
3). Lane 1 and 2 were input DNA and control IgG ChIP,
respectively.
(TIF)
Figure S2 One isoform of NaV1.5 is detected in HL-1 cells. RT-
PCR using a pair of m2NaV1.5 primers showed that there was
only one DNA band representative of NaV1.5 mRNA after 40
cycles. Overexpression of 50 MOI Foxo1-AA-GFP for 36 hours
decreased NaV1.5 mRNA level compared with that in cells
expressing 50 MOI GFP and the amount of sample loading was
equal as determined by GAPDH RT-PCR products.
(TIF)
Figure S3 RNAi targeting mouse Foxo1 mRNA does not affect
human Foxo1 expression. RT-PCR using a pair of hFoxo1
primers showed that human Foxo1 mRNA expression was not
altered in the HeLa cells infected with 50 MOI Adv-Foxo1-RNAi
(n=3) in comparison with the cells infected 50 MOI Adv-
scramble-RNAi (n=3) (A and B).
(TIF)
Figure S4 RNAi targeting mouse Foxo1 mRNA does not affect
TR4 mRNA expression. RT-PCR using a pair of TR4 primers
showed that TR4 mRNA expression was not altered in the HL-1
cells infected with Adv-Foxo1-RNAi (n=3) in comparison with
the cells infected Adv-scramble-RNAi (n=3) (A and B).
(TIF)
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